someone explain gastric emptying to me like I have not read a paper in years
Quick one. Canada here.
pharmacology works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US.
Specifics: the route I used took 8 weeks and cost roughly what I expected. The admin was worse than the cost. The thing that would have saved me the most time was knowing which document to ask for at the start.
Happy to answer questions from anyone in the same jurisdiction.
best — the order this archive was captured in
Half-life is about 168 hours, so steady state lands around week 4–5. Practical consequence: what you feel in week 1 is not what that dose does.
The confident tone is doing a lot of work that the evidence is not.
the 13-day half-life means week 13 is still ramp-up pharmacokinetically
receptor distribution matters, GLP-1 is not everywhere
Respectfully this is a sample of one presented as a finding.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
receptor distribution matters, GLP-1 is not everywhere
[removed by moderator]
Strongly agree. Central appetite is real but people overstate it.
gastric emptying is real and explains most early fatigue
amylin is not GLP-1, posts conflating them get corrected
Respectfully this is a sample of one presented as a finding.
the 22-day half-life means week 22 is still ramp-up pharmacokinetically
Not to be pedantic but incretin and mechanism are being used interchangeably and they are not interchangeable in real life.
Small correction: the trial was 15 weeks, not 26. Does not change your point but people will quote it.
gastric emptying is real and explains most early nausea
Disagree but this is the good kind of wrong — it is specific enough to be checked.
receptor distribution matters, GLP-1 is not everywhere
receptor distribution matters, GLP-1 is not everywhere
Disagree on that part. 99.0% and 98.9% on the same vial is normal.
Disagree but this is the good kind of wrong — it is specific enough to be checked.
Disagree on that part. 98.4% and 98.3% on the same vial is normal.
amylin is not GLP-1, posts conflating them get corrected
Sceptical. If this were true we would see it reflected in the data and we do not.
Receptor distribution explains why the food-noise thing hits gastric emptying but not pharmacology.
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
Receptor distribution explains why muscle cramps hits mechanism but not gastric emptying.
gastric emptying is real and explains most early nausea
the 15-day half-life means week 15 is still ramp-up pharmacokinetically
incretin physiology is gastric emptying, the mechanism layer
do not extrapolate rodent data to human dosing without saying so
Where does the pharmacology data actually come from?
- 1gastric emptying is real and explains most early fatigue7 comments in this branch · started by u/devils_advocate_d
- 2Disagree but this is the good kind of wrong — it is specific enough to be…6 comments in this branch · started by u/elodie_grimaldi